OpportunityTitle: Combating Overdose through Community-Level Intervention
Description: Overview The overdoses continue throughout the United States, claiming an alarming number of lives each year. Drug overdose is the leading cause of injury death in the United States, surpassing motor vehicle crashes since 2009.1 According to provisional data released by the Centers for Disease Control and Prevention (CDC), reported drug overdoses accounted for over 92,000 U.S. deaths in 2020, which is nearly a 30 percent increase from 2019. The new data release revealed other grim realities this past year: the most drug overdose deaths in a year; the most deaths from opioid overdoses; the most overdose deaths from stimulants like methamphetamine; the most deaths from the deadly class of synthetic opioids known as fentanyls. Moreover, the reported number of opioid-involved drug overdose deaths in the United States for the 12-month period ending in December 2020 (68,821) increased from 50,178 in the previous year. The drug overdose epidemic has been exacerbated during the COVID-19 pandemic, presenting new challenges to public health and public safety officials, medical professionals, local communities, and other stakeholders invested in curbing rates of accidental death. Preparing regional and community leaders to respond effectively to the public health emergency that is today&#8217;s drug overdose crisis (and be prepared to take on that crisis as it evolves during the COVID-19 pandemic) is essential for achieving the shared goal of preventing fatal overdose and saving lives. ONDCP expects to award one Federal cooperative agreement under the Combating Overdose through Community-Level Intervention Initiative (COCLI) for a 1-year period, beginning approximately September 2021. The successful non-Federal entity (NFE) will conduct research activities that entail implementing and evaluating community-based efforts to fight the overdose epidemic. These activities will be focused on the regions of the United States with some of the highest rates of fatal and non-fatal overdoses and will work to coordinate the often decentralized state and local efforts to assess and respond to overdoses. Efforts will also support and promote the partnership of law enforcement and public health agencies, as coordination and collaboration between these two groups is proving critical to addressing this epidemic. Efforts will also align with and be informed by related projects currently being conducted by ONDCP and CDC, and both agencies will work closely with the successful NFE. In particular, work conducted under this initiative will entail partnership with federally designated High Intensity Drug Trafficking Area (HIDTA) programs, which are funded by ONDCP and currently partner with the CDC under the Overdose Response Strategy initiative. Given the current COVID-19 pandemic, special consideration will be given to innovative strategies that expand efforts while adhering to safety guidelines established by the CDC. 1 Rudd RA, Seth P, David F, Scholl L. Increases in Drug and Opioid-Involved Overdose Deaths &#8212; United States, 2010&#8211;2015. MMWR Morb Mortal Wkly Rep 2016;65:1445&#8211;1452.4 Goals, Objectives and What the Government is Supporting The assistance provided under this award will support the NFE&#8217;s performance of the award and fulfillment of the following performance areas: &#8226; Research and analyze 1) a range of existing community-based efforts to address overdoses and 2) current evidence-based and proven strategies to reduce overdose deaths that incorporate approaches that advance equity; &#8226; Using the evidence-based approaches previously identified, implement or enhance community-based new or ongoing programs that aim to reduce overdose, particularly in the regions of the United States with the highest rates of fatal and non-fatal overdoses (priority will be given to proposals that make funding available to at least eight communities via subawards); &#8226; Once implemented, support the evaluation of these community-based efforts to assess their efficacy in reducing overdose and other harms of substance (mis)use, particularly in the regions of the United States with the highest rates of fatal and non fatal overdoses; &#8226; Support and promote collaboration between public safety and public health agencies to ensure that overdose reduction efforts are aligned and that communities benefit from a comprehensive and coordinated response; and &#8226; Provide technical assistance to support implementation, evaluation, and reporting by prospective subaward recipients. Authorizing Statutes and Governing Regulations Applicable to this Funding Opportunity: The authority for this opportunity is the SUPPORT for Patients and Communities Act, (Pub. L. No. 115-271), 21 U.S.C. &#167;&#167; 1701 et seq. and the Consolidated Appropriations Act, 2021 (Pub. L. No. 116-260) applicable appropriations statutes providing funding to ONDCP for this purpose. The Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards are applicable to the government and applicants, cooperative agreement applications, and cooperative agreement awards to non-Federal entities. See 2 C.F.R. Part 200 et seq., as adopted in full by ONDCP via 2 C.F.R. Part 3603 et seq. Federal Award Information ONDCP expects to award one Federal cooperative agreement under the Combating Overdose through Community-Level Intervention Initiative (COCLI), for a 1-year period, beginning approximately September 2021. All applications and awards are subject to such additional requirements expressed in governing law. See 2 C.F.R. Part 200 et seq. ONDCP expects that it will make an award of financial assistance from this announcement in the form of a cooperative agreement. Estimated Amount and Length of AwardCooperative Agreement Amount: $3,000,000 Projected Award Date: No later than September 2021 Projected Project Period 12 months [September 2021 &#8211; August 2022] Financial Management and System of Internal Controls If selected for funding, the NFE must: (a) Establish and maintain effective internal controls over the Federal award that provides reasonable assurance that the non-Federal entity is managing the Federal award in compliance with Federal statutes, regulations, and the terms and conditions of the Federal award. These internal controls should be in compliance with the guidance in &#8220;Standards for Internal Control in the Federal Government,&#8221; issued by the Comptroller General of the United States and the &#8220;Internal Control Integrated Framework,&#8221; issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). (b) Comply with Federal statutes, regulations, and the terms and conditions of the Federal awards. (c) Evaluate and monitor the non-Federal entity&#8217;s compliance with statute, regulations, and the terms and conditions of the Federal awards. (d) Take prompt action when instances of noncompliance are identified, including noncompliance identified in audit findings. (e) Take reasonable measures to safeguard protected personally identified information and other information the Federal awarding agency or pass-through entity designates as sensitive or the non-Federal entity considers sensitive consistent with applicable Federal, state, and local laws regarding privacy and obligations of confidentiality. Eligibility Information ONDCP encourages applications from non-profit organizations with expert knowledge and experience in developing or enhancing new or ongoing programs that aim to reduce overdose through strategic, evidence-based approaches. Neither cost sharing nor matching are requirements for application eligibility
GrantorContactEmailDescription: Program Manager
GrantorContactText: Jayme Delano &lt;br/&gt;Phone 202-395-6794